The Recall Desk
ModerateFDA (Devices)·Z-1107-2014·Announced 2014-03-05

Philips HeartStart XL+ Defibrillator Recalled for Battery Charge Time Labeling Error

Philips is recalling 7,157 HeartStart XL+ Defibrillators because the battery charge time at high temperatures is slightly longer than the 3 hours stated in the labeling.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text describes a minor labeling error regarding battery charge time without reporting any illnesses, injuries, or hospitalizations, fitting the criteria for a moderate severity score.

Plain-English summary

Philips Medical Systems, Inc. is recalling 7,157 units of the HeartStart XL+ Defibrillator/Monitor (Model 861290). The recall is due to a labeling inaccuracy regarding the device's battery performance. Specifically, the time required to charge the battery to 100% capacity at 35°C (95°F) is slightly longer than the 3-hour duration specified in the product labeling.

The affected devices were distributed worldwide, including the United States (nationwide) and Puerto Rico, as well as numerous countries across Africa, Asia, Europe, and the Americas. The HeartStart XL+ is intended for use in hospital settings by qualified medical personnel trained in basic life support, advanced life support, or defibrillation.

No specific corrective actions or consumer instructions are provided in the source text beyond the identification of the labeling discrepancy. Users should verify their device serial numbers against the provided ranges to determine if their unit is affected.

The recalled product

Product
Philips HeartStart XL+ Defibrillator/Monitor Model: 861290 The HeartStart XL+ is intended for use in a hospital setting by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced life support or defibrillati
Affected units
7,157

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically: